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Abstract 
The present study was carried out to explore phytochemically and pharmacologically the 
medicinal plant botanically classified as Millettia ovalifolia. The structure of the isolated 
compound 3,7-Dihydroxy-2-phenyl-4H-chromen-4-one was confirmed by modern 
spectroscopic techniques besides its comparison with analytical data available in literature. 
The compound was further studied for lipoxygenase (LOX) inhibitory activity and docking 
studies. The compound was found to reveal important LOX inhibitory potential with the IC50 
value 31.92±0.02 μM.  The molecular docking study further showed the important molecular 
interactions between the compound and LOX displaying encouraging activity for more 
optimization as an approaching anti-inflammatory lead compound. The results showed that 
this plant is very significant and can act as a source to treat inflammation. 
Keywords: Millettia ovalifolia, 3,7-Dihydroxy-2-phenyl-4H-chromen-4-one, Lipoxygenase, 
Inflammation, Docking. 
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INTRODUCTION 
The genus Millettia consists of around 150 species 
which are distributed in the tropical and subtropical areas of 
the globe. Out of which only two species exist in Pakistan 
i.e., M. extensa and M. peguensis (Ali, 1977). Some 
species belonging to the genus Millettia showed fish 
poisoning activity. Flavones, flavonones, flavans, 
flavanoles, prenylated isoflavones, chalcones, pongamol, 
lancelolatin, kanjone, ovalitenone, milletenone and 
pongaglabol have been reported from this genus (Sritularak 
et al., 2002). Some species of this genus contain 
hypotensive agents (Ngamga et al., 2007). 
The flavonoids of genus Millettia such as chalcones 
showed antimalarial activity (Yenesew et al., 2003). 
Isoflavonoids such as maximaisoflavone and griffonianone 
are also isolated from the species of this genus (Yankep et 
al., 2001). A new isoflavan-quinone, named, 
laurentiquinone along with flavonol named as laurentinol 
have been isolated from this genus in addition to two 
known isoflavones, glyricidin and calycosin (Kamnaing et 
al., 1999). The genus Millettia also contains, cis-jasmone 
used as an activator for secondary metabolism of wheat 
seedlings (Moraes et al., 2008). Other compounds such as 
maximaisoflavone-G, barbigerone, Jamaicin, 
isoliquiritigenin and O-geranylisoliquiritigenin are reported 
from various species (Yenesew et al., 1998). Four 
compounds namely N-Ethylacetamide, (E)-Ethyl 13-(3,4-
dimethoxyphenyl) acrylate, (E)-Methyl 3-(3,4-
dimethoxyphenyl) acrylate and 3,7-Dihydroxy-2-phenyl-4H-
chromen-4-one were isolated from M. ovalifolia which 
exhibited significant docking interaction with different 
enzymes (Rahman et al., 2017). 
In the present research study, a compound known as 
3,7-Dihydroxy-2-phenyl-4H-chromen-4-one was isolated 
with capable lipoxygenase inhibitory potential along with 
computational insights based on molecular docking.  
 
MATERIALS AND METHODS 
Plant material 
The plant material was collected in June 2008 from 
Pakistan. The plant was authenticated at the Botany 
Department of Islamia College University, Peshawar, 
Pakistan. The voucher specimen (SJ-33) was placed in the 
herbarium of the Department of Department, Islamia 
University, Peshawar, Pakistan.  
Extraction and isolation  
The shade dried and crushed (70 kg) stem bark was 
soaked for one week (x 3) in 5% water and methanol. The 
crude extract was concentrated by a vacuum rotary 
evaporator under reduced pressure to gained brownish 
residue F1 (5 kg) which was further suspended in water 
and partitioned with different organic solvents like n-
hexane, chloroform, ethyl acetate and insoluble fraction. To 
get n-hexane fraction FX1 (1.2 kg), chloroform fraction FX2 
(1.6 kg), ethyl acetate fraction FX3 (1.0 kg) and insoluble 
fraction FX4 (0.8 kg). The chloroform fraction FX2 (500 g) 
was further subjected to column chromatography using 
silica gel and eluted with n-hexane: chloroform in 
increasing order of polarity from which several fractions 
were obtained, which were further combined on the basis 
of TLC and yield(1-6).  The fractions 3 (14.3 g), fraction 4 
(25 g) and fraction 5 (19.7 g) were combined together on 
the basis of TLC which was re-chromatographed using 
silica gel and eluted with n-hexane and chloroform in 
increasing order of polarity and 56 fractions were obtained. 
Fractions 20-40 were combined together on the base of 
TLC and were purified by Preparative TLC which resulted 
in the isolation of a new source compound (12 mg). The 
structure of the isolated compound was further confirmed 
by different modern spectroscopic techniques and its 
comparison with already reported data in the literature 
available (Figure 1) (Ngandeu et al., 2008). 
 
 
Fig. 1. Chemical structure of 3,7-Dihydroxy-2-phenyl-
4H-chromen-4-one. 
 
Molecular docking simulations 
In this study, the FRED 2.1 (Mcgann et al., 2003; Khan 
et al., 2009) was used to dock the OMEGA pre-generated 
multi-conformer library cited above. FRED 2.1 approach is 
to fully dock/score all the probable sites of each ligand in 
the binding site. The complete exploration is based on rigid 
rotations and translations of each conformer within the 
binding site defined by a box. FRED examined the 
positions joint by refusing the ones that clank with the 
protein (LOX) or that doesn’t have sufficient interactions 
with the protein. The final positions can then be scored or 
re-scored using one or more than one scoring functions. In 
the current study, the smooth shape-based Gaussian 
scoring function (shape gauss) was chosen to assess the 
shape complementarily between each ligand and binding 
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pocket. Default FRED protocol was used except for the 
size of the box defining the binding sites. In an effort to 
improve the docking-scoring performance, we made 
complete docking with shape gauss applying the 
"Optimization" mode. The "Optimization" mode involves a 
systematic solid body optimization of the upper ranked 
positions from the exhaustive docking. Three different 
boxes were investigated for LOX. Three dissimilar 
simulations were carried out with an added value of 8 Å 
around the reference ligand. 
Lipoxygenase inhibition assay  
The lipoxygenase inhibition activity was carried out by 
using various concentrations of the isolated compound. 
The lipoxygenase inhibitory potential was measured by a 
slight modification in the spectrometric method as earlier 
reported (Khan et al., 2009; Khan et al., 2011). 
Lipoxygenase (EC 1.13.11.12) type I-B and linoleic acid 
were got from Sigma (St. Louis, MO) and were used 
without additional purification. All the chemicals were of 
analytical grade and purchased from Sigma (St. Louis, 
MO). 160μl of sodium phosphate buffer, 0.1 mM (pH 7.0), 
10ml of the test compound and standards and 20μL of 
lipoxygenase solution were mixed together and further 
incubated at 258 
◦
C for 5 minutes. The reaction was started 
by adding of 10μl linoleic acid substrate solution and 
absorption change with the formation of (9Z, 11E)-13S)-13-
hydroperoxyo-ctadeca-9,11-dienoate was followed for 10 
minutes. The test sample and control were dissolved in 
50% of ethanol. All the reactions were made in triplicate. 
Tenidap sodium and Baicalein were used as positive 
controls for LOX inhibition (Khan et al., 2009). Using the 
EZFit Enzyme Kinetics (Perrella Scientific Inc., Amherst, 
USA) program the IC50 values were calculated. The results 
were expressed as mean±S.E.M.  
 
RESULTS AND DISCUSSION 
In vitro lipoxygenase inhibition assay 
In the current study, the compound revealed significant 
LOX inhibitory activity with (IC50 value: 31.92±0.02 μM), 
while the standards Tenidap sodium and Baicalein 
exhibited the IC50 value 22.1±0.03μM and 41.6±0.02 μM 
respectively. 
Molecular docking simulations 
Molecular insights of the compound revealed 
significant molecule interactions (Figures 2-4) with the 
active site (catalytic triad and iron atom) of LOX. Favorable 
hydrogen bonding and other attractive forces between the 
ligand and proteins were the main causes behind its 
promising LOX inhibitory potential. The O (oxygen) atom at 
position 1 of ring B of the compound was found to be 
interacting with His518 at a distance of 3.17 °A through 
hydrogen bonding. Hydroxyl moiety at position 7 of ring A 
has shown its favorable molecular contacts via hydrogen 
bonding with Ileu857 at a distance of 3.00°A. Furthermore, 
π-π interactions between ring A with His523 at a distance 
of 3.92°A. Methoxy group of Ring A at position 6 of the 
compound showed charge-dipole interactions with Iue557. 
In order to further improve the activity of the compound, 
methoxy group should be replaced by a more polar and 
bulky group that will penetrate deeply into the adjoin pocket 
of the active site due to favorably enhanced steric and 
electrostatic interactions. Lipoxygenase (EC 1.13.11.12) 
constitutes a family of nonheme iron comprising enzymes, 
as multipurpose biocatalysts are proficient of catalyzing 
various reactions involved in xenobiotic metabolism. They 
are responsible for the metabolism of the fatty acids and 
their metabolites provoking inflammatory responses in the 
body. In cancer cell growth they also show an important 
role, invasiveness, metastasis, induction of tumor necrosis 
factor (TNF) and cell survival (Nisar et al., 2011). The active 
or catalytic site of LOX is composed of three significant 
amino acid residues the so-called catalytic triad (His523, 
His518, Ile875) along with iron atom. Any compound can 
be developed as new and therapeutically effective LOX 
inhibitor which is proficient to display strong molecular 
interaction with the catalytic triad.  
 
 
Fig. 2. Binding mode of the compound inside catalytic 
site of lipoxygenase. Orange colored round object is 
Fe atom. Hydrogen bonding (green dotted lines) are 
selectively (only for His523 and His519,) shown for 
clarity. Hydrogen atoms (except polar ones) were 
omitted for clarity. 
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Fig 3. Closer view of molecular interactions of the 
compound inside catalytic site of lipoxygenase.  
Orange colored round object is Fe atom. Hydrogen 
atoms (except polar ones) were omitted for clarity.  
 
 
Fig. 4. Electrostatic interactions of the compound 
inside active site of LOX. Color encoding (White area: 
hydrophobic region, red area: area with aggregated 
negative electrostatic potential, and blue area: area 
with aggregated positive electrostatic potential). 
 
CONCLUSION 
In the present study, the 3,7-Dihydroxy-2-phenyl-4H-
chromen-4-one isolated from M. ovalifolia was studied for 
lipoxygenase inhibitory activity and docking studies and 
was found to reveal important LOX inhibitory potential with 
the IC50 value 31.92±0.02 μM.  The molecular docking 
study further exposed important molecular interactions 
between the compound and LOX.  The test compound has 
a significant profile as a possible lead compound for the 
cure of inflammation and associated pathological 
conditions.  
 
ACKNOWLEDGMENTS 
We are highly thankful to the Department of Chemistry, 
Mohi-Udin Islamic University, AJ&K, Pakistan, for 
supporting this research.  
 
CONFLICT OF INTEREST 
Authors declare no competing interests. 
 
REFERENCES 
Ali, S.I., 1977. Flora of Pakistan: Shamim Printing Press: 
Karachi. 100, pp 51-52.  
Kamnaing, P., Free, S.N.F., Nkengfack, A.E., Folefoc, G., 
Fomum, Z.T., 1999. An isoflavan-quinone and a 
flavonol from Millettia laurentii. Phytochem., 51(6): 829-
832. 
Khan, I., Nisar, M., Ebad, F., Nadeem, S., Saeed, M., 
Khan, H., Khuda, F., Karim, N., Ahmad, Z., 2009. Anti-
inflammatory activities of Sieboldogenin from Smilax 
china Linn.: experimental and computational studies. J. 
Ethnopharmacol., 121(1): 175-177. 
Khan, I., Nisar, M., Shah, M.R., Shah, H., Gilani, S.N., Gul, 
F., Abdullah, S.M., Ismail, M., Khan, N., Kaleem, W.A., 
Qayum, M., 2011. Anti-inflammatory activities of 
Taxusabietane A isolated from Taxus wallichiana 
Zucc. Fitoterapia, 82(7): 1003-1007. 
Mcgann, M.R., Almond, H.R., Nicholls, A., Grant, J.A., 
Brown, F.K., 2003. Gaussian docking 
functions. Biopolymers, 68(1), pp.76-90. 
Moraes, M.C.B., Birkett, M.A., Gordon-Weeks, R., Smart, 
L.E., Martin, J.L., Pye, B.J., Bromilow, R., Pickett, J.A., 
2008. cis-Jasmone induces accumulation of defence 
compounds in wheat, Triticum 
aestivum. Phytochem., 69(1): pp.9-17. 
Ngamga, D., Free, S.F., Tane, P., Fomum, Z.T., 2007. 
Millaurine A, a new guanidine alkaloid from seeds of 
Millettia laurentii. Fitoterapia, 78(3): 276-277. 
Ngandeu, F., Bezabih, M., Ngamga, D., Tchinda, A.T., 
Ngadjui, B.T., Abegaz, B.M., Dufat, H., Tillequin, F., 
2008. Rotenoid derivatives and other constituents of 
the twigs of Millettia duchesnei. Phytochem., 69(1): 
258-263. 
Nisar, M., Kaleem, W.A., Khan, I., Adhikari, A., Khan, N., 
Shah, M.R., Khan, I.A., Qayum, M., Ismail, M., Aman, 
A., 2011. Molecular simulations probing Kushecarpin A 
  
Biological Research                                                             2018;  3(3):120-124 
 
124 
                                                                                                   
as a new lipoxygenase inhibitor. Fitoterapia, 82(7): 
1008-1011. 
Rahman, T.U., Zeb, M.A., Hussain, S., Liaqat, W., 2017. 
Physiochemical extraction, spectroanalytical 
identification, antibacterial and docking studies of four 
new source phytochemicals from the bark of Millettia 
ovalifolia.  Int. J. Biosci., 11(1): 222-231. 
Sritularak, B., Likhitwitayawuid, K., Conrad, J., Kraus, W., 
2002. Flavonoids from the roots of Millettia 
erythrocalyx. Phytochem., 61(8): 943-947. 
Yankep, E., Mbafor, J.T., Fomum, Z.T., Steinbeck, C., 
Messanga, B.B., Nyasse, B., Budzikiewicz, H., Lenz, 
C., Schmickler, H., 2001. Further isoflavonoid 
metabolites from Millettia griffoniana 
(Bail). Phytochem., 56(4): 363-368. 
Yenesew, A., Derese, S., Midiwo, J.O., Oketch-Rabah, 
H.A., Lisgarten, J., Palmer, R., Heydenreich, M., Peter, 
M.G., Akala, H., Wangui, J., Liyala, P., 2003. Anti-
plasmodial activities and X-ray crystal structures of 
rotenoids from Millettia usaramensis subspecies 
usaramensis. Phytochem., 64(3): 773-779. 
Yenesew, A., Midiwo, J.O., Waterman, P.G., 1998. 
Rotenoids, isoflavones and chalcones from the stem 
bark of Millettia usaramensis subspecies 
usaramensis. Phytochem., 47(2): 295-300. 
 
